New 3D bioprinted model to study common liver disease, find effective treatment
Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly ...
Jan 23, 2024
0
0